Strategic Management and Sustainability

Strategic Management and
Sustainability

Table of Contents
Introduction....................................................................................................................................1
MAIN BODY..................................................................................................................................1
Key business strategies within last five years and find work to discuss strategy changed and
pursued.........................................................................................................................................1
Resource and capabilities of company over the last five years...................................................1
Revelation of how company can implement environmental sustainability and they are thinking
to become more competitive........................................................................................................1
CONCLUSION..............................................................................................................................1
REFERENCE.................................................................................................................................1

Introduction
A sustainable management is the intersection of the business and sustainability. It is the practise
of managing organisational impact on the three bottom lines that covers profit, people and planet
So that all three can proposer in the future.
This report will cover the study of AstraZeneca plc Which is British British multinational
pharmaceutical company who are having headquarters in Cambridge England. they are having
huge portfolio of product for some of the major diseases like infections, Oncology, Respiratory
etc. It is perhaps best known for there involvement in developing covered vaccine called Oxford-
AstraZeneca.
This report will identify key business strategies of the AstraZeneca plc within past five years by
using the framework to discuss why this strategy was pursued or changed. It will also identify
the evidence sources and capability of AstraZeneca plc over the past five years and Analysation
of what extent the company has aligned there capability and sources to their business strategies.
In the end of this report will conclude environmental sustainability, theories and way of thinking
to become more competitive.

MAIN BODY
Key business strategies within last five years and find work to discuss strategy changed and
pursued
AstraZeneca Is one of the leading pharmaceutical company who are having huge reputation in
all over the world, in between last five years they have implemented various strategies that
helped them to take competitive advantages some of them may changed with the time and some
of their pursued newly. late stage pipeline transformed well ahead of plan through the increase
research and productivity, accelerate the target business development and accelerate
programmes, company has come up with the 14 potential new medicines that across the base 3 or
registration, potential for 16 to 14 submissions an 18 to 10 approvals company get in year 2015
to 16 (Baumgartner, and Rauter., 2017.
). Industry leading immuno- oncology Portfolio with the combination of 13 trials that undertake
and 16 are planned by the company, acquisitions help to define and accelerate the further clinical
programmes through the prognostic biomarker testing and precise predictive test.
The five current growth of the organisation on the platform are emergency markets, Brillianta,
repertory, donates. They have also opened the new accounts for more than half of their global
revenue Ray showing their growth within the market.! their business is taking the shape Neil
evolving to become more profitable and sustainable on the global level, biologics account for
new nearly 50% of pipeline, Increasing the probability of success an enhancing companies
durability that is along with the growing focus on portfolio balance on the devices of primary and
specialty care boost probability,. Oncology Is the most important therapeutic Area in which
AstraZeneca company has the good knowledge and deep rooted heritage. It will potentially
transformational for the future of company and there becoming the 6th fastest growing platform
in all over the world. their vision is to help patients and the treatment of cancer. By 2020 their
aim is to bring 6 new cancer medicine for the patients so they can recover more faster and feel
better by taking the medicines.
The positive CHMP Opinion get for the lynparza, In the EUEuropean and we they anticipate
European and US approvals in the first quarter of 2015 with further studies ongoing and gastric,
breast and pancreatic Cancers and early stage activities of the cancer.
PESTEL Analysis of AstraZeneca